Evidence map›Paper›PMID 31776469›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

De novo CLTC variants are associated with a variable phenotype from mild to severe intellectual disability, microcephaly, hypoplasia of the corpus callosum, and epilepsy.

Maria J Nabais Sá, Hanka Venselaar, Laurens Wiel, Aurélien Trimouille, Eulalie Lasseaux, Sophie Naudion, Didier Lacombe, Amélie Piton, Catherine Vincent-Delorme, Christiane Zweier and 20 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Intellectual developmental disorder 56 associated with novel variants in the clathrin heavy chain encoding CLTC gene and brief review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  7. Article
  8. Mosaic CLTC pathogenic variant causing focal epilepsy with normal intelligence.Epileptic disorders : international epilepsy journal with videotape · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 11 institutions in 7 countries.

Maria J Nabais SáDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.
Hanka VenselaarCenter for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences (RIMLS), Radboudumc, Nijmegen, The Netherlands.
Laurens WielCenter for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences (RIMLS), Radboudumc, Nijmegen, The Netherlands.
Aurélien TrimouilleDepartment of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Eulalie LasseauxDepartment of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Sophie NaudionDepartment of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Didier LacombeDepartment of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Amélie PitonInstitut de Genetique et de Biologie Moleculaire et Cellulaire, Illkirch-Graffenstaden, France.
Catherine Vincent-DelormeService de Génétique Clinique Guy Fontaine Hôpital Jeanne de Flandre, CHRU, Lille, France.
Christiane ZweierInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
André ReisInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Regina TrollmannDepartment of Pediatrics, Division of Neuropediatrics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Anna RuizGenetics Laboratory, UDIAT-Centre Diagnòstic, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
Elisabeth GabauPaediatric Unit, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
Annalisa VetroMeyer Children's Hospital, University of Florence, Florence, Italy.
Renzo GuerriniMeyer Children's Hospital, University of Florence, Florence, Italy.
Somayeh BakhtiariBarrow Neurological Institute, Phoenix Children's Hospital & University of Arizona College of Medicine, Phoenix, AZ, USA.
Michael C KruerBarrow Neurological Institute, Phoenix Children's Hospital & University of Arizona College of Medicine, Phoenix, AZ, USA.
David J AmorMurdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.
Monica S CooperMurdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.
Emilia K BijlsmaDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Tahsin Stefan BarakatDepartment of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Marieke F van DoorenDepartment of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Marjon van SlegtenhorstDepartment of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Rolph PfundtDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.
Christian GilissenDepartment of Human Genetics, RIMLS, Radboudumc, Nijmegen, The Netherlands.
Michèl A WillemsenDepartment of Pediatric Neurology, Radboud University Medical Center and Donders Institute for Brain, Cognition and Behavior, Amalia Children's Hospital, Nijmegen, The Netherlands.
Bert B A de VriesDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.
Arjan P M de BrouwerDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.
David A KoolenDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands. david.koolen@radboudumc.nl.ORCID http://orcid.org/0000-0002-2152-4626
Radboud University Nijmegen · NLErasmus MC · NLFriedrich-Alexander-Universität Erlangen-Nürnberg · DEBarrow Neurological Institute · USMeyer Children's Hospital · ITRoyal Children's Hospital · AUUniversitat Autònoma de Barcelona · ESUniversité de Bordeaux · FRHôpital Jeanne de Flandre · FRInserm · FRLeiden University Medical Center · NL

Funding

Genomic Insights into the Neurobiology of Cerebral PalsyR01NS106298 · NINDS · UNIVERSITY OF ARIZONA · PI KRUER, MICHAEL C · 2019 to 2023
$3.7M
6 · The paper itself

Abstract

purposeTo delineate the genotype-phenotype correlation in individuals with likely pathogenic variants in the CLTC gene.

methodsWe describe 13 individuals with de novo CLTC variants. Causality of variants was determined by using the tolerance landscape of CLTC and computer-assisted molecular modeling where applicable. Phenotypic abnormalities observed in the individuals identified with missense and in-frame variants were compared with those with nonsense or frameshift variants in CLTC.

resultsAll de novo variants were judged to be causal. Combining our data with that of 14 previously reported affected individuals (n = 27), all had intellectual disability (ID), ranging from mild to moderate/severe, with or without additional neurologic, behavioral, craniofacial, ophthalmologic, and gastrointestinal features. Microcephaly, hypoplasia of the corpus callosum, and epilepsy were more frequently observed in individuals with missense and in-frame variants than in those with nonsense and frameshift variants. However, this difference was not significant.

conclusionsThe wide phenotypic variability associated with likely pathogenic CLTC variants seems to be associated with allelic heterogeneity. The detailed clinical characterization of a larger cohort of individuals with pathogenic CLTC variants is warranted to support the hypothesis that missense and in-frame variants exert a dominant-negative effect, whereas the nonsense and frameshift variants would result in haploinsufficiency.

Indexed as

EpilepsyIntellectual DisabilityMicrocephalyBiological Variation, PopulationCorpus CallosumHumansPhenotypeCLTCintellectual disabilityneurodevelopmental disorder

Identifiers

PMID31776469
OpenAlexW2989820740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.